6.29 KS Critically important antimicrobials and mastitis (APR 2021)
Strategies to refining antimicrobial use are critical to reducing antimicrobial resistance
Antibiotic Use and Resistance
Antimicrobial use and resistance of bacteria to antibiotics is a major issue as bacteria can transfer between species and environments, and bacteria can acquire material from other bacteria that make them resistant. This could lead to relatively harmless bacteria coming in contact with another more dangerous type of bacteria and essentially handing over the genetic blueprints to resist one or more of our most commonly used antibiotics, eventually leading to “superbugs,” bacteria that cannot be treated with most antibiotics anymore.
Do you have any questions for our experts? To submit your questions and view questions previously answered by our experts, visit the ‘Ask an Expert’ page!
In this month’s first research summary, the use of critically important antimicrobials (CIA), important to human health, vs non-CIA in the treatment of mastitis is reviewed. In the second research summary, a probiotic is evaluated for its ability to offer protection against uterine infections post calving.
Strategies to refining antimicrobial use are critical to reducing antimicrobial resistance
Using lactic acid treatments to reduce uterine infections and improve reproductive performance
This month, DRECA’s interview continues with Drs. Barkema, McCubbin and Smid regarding their work on antimicrobial use and resistance.